Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Children's Hospital of Philadelphia
Incyte Corporation
University of Michigan Rogel Cancer Center
Novartis
Blueprint Medicines Corporation
Dana-Farber Cancer Institute
Novartis
Novartis
OnKure, Inc.
University of Pennsylvania
Novartis
Dana-Farber Cancer Institute
University of Utah
Novartis